The effect of polymorphisms of the β2-adrenergic receptor on the response to regular use of albuterol in asthma

American Journal of Respiratory and Critical Care Medicine

Volumn 162, Issue 1, 2000, Pages 75-80

  Israel, Elliot ^{a,b,c,d,e,f,g,h,i,j}   Drazen, Jeffrey M ^{a,b,c,d,e,f,g,h,i,j}   Liggett, Stephen B ^{a,b,c,d,e,f,g,h,i,j}   Boushey, Homer A ^{a,b,c,d,e,f,g,h,i,j}   Cherniack, Reuben M ^{a,b,c,d,e,f,g,h,i,j}   Chinchilli, Vernon M ^{a,b,c,d,e,f,g,h,i,j}   Cooper, David M ^{a,b,c,d,e,f,g,h,i,j}   Fahy, John V ^{a,b,c,d,e,f,g,h,i,j}   Fish, James E ^{a,b,c,d,e,f,g,h,i,j}   Ford, Jean G ^{a,b,c,d,e,f,g,h,i,j}   Kraft, Monica ^{a,b,c,d,e,f,g,h,i,j}   Kunselman, Susan ^{a,b,c,d,e,f,g,h,i,j}   Lazarus, Stephen C ^{a,b,c,d,e,f,g,h,i,j}   Lemanske Jr , Robert F ^{a,b,c,d,e,f,g,h,i,j}   Martin, Richard J ^{a,b,c,d,e,f,g,h,i,j}   Mclean, Diane E ^{a,b,c,d,e,f,g,h,i,j}   Peters, Stephen P ^{a,b,c,d,e,f,g,h,i,j}   Silverman, Edwin K ^{a,b,c,d,e,f,g,h,i,j}   Sorkness, Christine A ^{a,b,c,d,e,f,g,h,i,j}   Szefler, Stanley J ^{a,b,c,d,e,f,g,h,i,j}   Weiss, Scott T ^{a,b,c,d,e,f,g,h,i,j}   Yandava, Chandri N ^{a,b,c,d,e,f,g,h,i,j}   more..

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d HARLEM HOSPITAL CENTER   (United States)

^e MONTEFIORE MEDICAL CENTER   (United States)

^f PENN STATE COLLEGE OF MEDICINE   (United States)

^g UNIVERSITY OF WISCONSIN MADISON   (United States)

^h UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

ⁱ NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^j THOMAS JEFFERSON UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; BETA 2 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; SALBUTAMOL;

ARTICLE; ASTHMA; CODON; DNA POLYMORPHISM; DRUG EFFECT; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PEAK EXPIRATORY FLOW; PHARMACOGENETICS; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0033915078     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.162.1.9907092     Document Type: Article

References (31)

1. 1. Nelson, H. S. 1995. Beta-adrenergic bronchodilators. N. Engl. J. Med. 333: 499-506.
2. 2. Sears, M. R., D. R. Taylor, C. G. Print, D. C. Lake, Q. Q. Li, E. M. Flannery, D. M. Yates, M. K. Lucas, and G. P. Herbison. 1990. Regular inhaled beta-agonist treatment in bronchial asthma. Lancet 336:1391-1396.
3. 3. Pearlman, D. S., P. Chervinsky, C. LaForce, J. M. Seltzer, D. L. Southern, J. P. Kemp, R. J. Dockhorn, J. Grossman, R. F. Liddle, and S. W. Yancey. 1992. A comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthma. N. Engl. J. Med. 327:1420-1425.
4. 4. Chapman, K. R., S. Kesten, and J. P. Szalai. 1994. Regular vs as-needed inhaled salbutamol in asthma control. Lancet 343:1379-1382.
5. 5. McFadden, E. R., Jr. 1995. Perspectives in beta 2-agonist therapy: vox clamantis in deserto vel lux in tenebris? J. Allergy Clin. Immunol. 95: 641-651.
6. 6. Sears, M. R. 1995. Is the routine use of inhaled beta-adrenergic agonists appropriate in asthma treatment? No. Am. J. Respir. Crit. Care Med. 151:600-601.
7. 7. Wanner, A. 1995. Is the routine use of inhaled beta-adrenergic agonists appropriate in asthma treatment? Yes. Am. J. Respir. Crit. Care Med. 151:597-599.
8. 8. Drazen, J. M., E. Israel, H. A. Boushey, V. M. Chinchilli, J. V. Fahy, J. E. Fish, S. C. Lazarus, R. F. Lemanske, R. J. Martin, S. P. Peters, C. Sorkness, and S. J. Szefler, for the National Heart, Lung, and Blood Institute's Asthma Clinical Research Network. 1996. Comparison of regularly scheduled with as-needed use of albuterol in mild asthma. N. Engl. J. Med. 335:841-847.
9. 2-adrenergic receptor in normal and asthmatic subjects. Am. J. Respir. Cell Mol. Biol. 8:334-339.
10. 10. Green, S. A., G. Cole, M. Jacinto, M. Innis, and S. B. Liggett. 1993. A polymorphism of the human beta 2-adrenergic receptor within the fourth transmembrane domain alters ligand binding and functional properties of the receptor. J. Biol. Chem. 268:23116-23121.
11. 11. Green, S. A., J. Turki, M. Innis, and S. B. Liggett. 1994. Amino-terminal polymorphisms of the human beta 2-adrenergic receptor impart distinct agonist-promoted regulatory properties. Biochemistry 33:9414-9419.
12. 12. Turki, J., J. N. Lorenz, S. A. Green, E. T. Donnelly, M. Jacinto, and S. B. Liggett. 1996. Myocardial signaling defects and impaired cardiac function of a human beta 2-adrenergic receptor polymorphism expressed in transgenic mice. Proc. Natl. Acad. Sci. U.S.A 93:10483-10488.
13. 13. Green, S. A., J. Turki, P. Bejarano, I. P. Hall, and S. B. Liggett. 1995. Influence of beta(2)-adrenergic receptor genotypes on signal transduction in human airway smooth muscle cells. Am. J. Respir. Cell Mol. Biol. 13:25-33.
14. 14. Turki, J., J. Pak, S. A. Green, R. J. Martin, and S. B. Liggett. 1995. Polymorphisms of the beta 2-adrenergic receptor in nocturnal and non-nocturnal asthma: evidence that Gly16 correlates with the nocturnal phenotype. J. Clin. Invest. 95:1635-1641.
15. 15. Hall, I. P., A. Wheatley, P. Wilding, and S. B. Liggett. 1995. Association of Glu 27 beta 2-adrenoceptor polymorphism with lower airway reactivity in asthmatic subjects. Lancet 345:1213-1214.
16. 16. Ohe, M., M. Munakata, N. Hizawa, A. Itoh, I. Doi, E. Yamaguchi, Y. Homma, and Y. Kawakami. 1995. Beta 2 adrenergic receptor gene restriction fragment length polymorphism and bronchial asthma. Thorax 50:353-359.
17. 17. Tan, S., I. P. Hall, J. Dewar, E. Dow, and B. Lipworth. 1997. Association between beta2-adrenoceptor polymorphism and susceptibility to bronchodilator desensitisation in moderately severe stable asthmatics. Lancet 350:995-999.
18. 18. Hancox, R. J., M. R. Sears, and D. R. Taylor. 1998. Polymorphism of the beta 2-adrenoceptor and the response to long-term beta 2-agonist therapy in asthma. Eur. Respir. J. 11:589-593.
19. 19. Martinez, F. D., P. E. Graves, M. Baldini, S. Solomon, and R. Erickson. 1997. Association between genetic polymorphisms of the beta 2-adrenoceptor and response to albuterol in children with and without a history of wheezing. J. Clin. Invest. 100:3184-3188.
20. 2-adrenergic receptor and asthma. Am. J. Respir. Crit. Care Med. 156(Suppl.):156-S162.
21. 21. Maniatis, T., E. F. Fritsch, and J. Sambrook. 1982. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory, New York.
22. 22. Newton, C. R., L. E. Heptinstall, C. Summers, M. Super, M. Schwarz, R. Anwar, A. Graham, J. C. Smith, and A. F. Markham. 1989. Amplification refractory mutation system for prenatal diagnosis and carrier assessment in cystic fibrosis. Lancet 2:1481-1483.
23. 23. Newton, C. R., A. Graham, L. E. Heptinstall, S. J. Powell, C. Summers, N. Kalsheker, J. C. Smith, and A. F. Markham. 1989. Analysis of any point mutation in DNA: the amplification refractory mutation system (ARMS). Nucleic Acids Res. 17:2503-2516.
24. 24. Vonesh, E. F., and R. L. Carter. 1987. Efficient inference for random-coefficient growth curve models with unbalanced data. Biometrics 43:617-628.
25. 25. Laird, N. M., C. Donnelly, and J. H. Ware. 1992. Longitudinal studies with continuous responses. Stat. Methods Med. Res. 1:225-247.
26. 26. National Asthma Education Program. 1997. Guidelines for the Diagnosis and Treatment of Asthma II. National Institutes of Health, Bethesda, MD.
27. 27. National Heart Lung and Blood Institute. 1995. NHLBI/WHO Workshop Report: Global Strategy for Asthma Management and Prevention. Global Initiative for Asthma. National Heart, Lung, and Blood Institute, Bethesda, MD. Publication No. 95-3659.
28. 28. Chervinsky, P., A. van As, E. A. Bronsky, R. Dockhorn, M. Noonan, C. LaForce, and W. Pleskow. 1994. Fluticasone propionate aerosol for the treatment of adults with mild to moderate asthma. J. Allergy Clin. Immunol. 94:676-683.
29. 29. Haahtela, T., M. Jarvinen, T. Kava, K. Kiviranta, S. Koskinen, K. Lehtonen, K. Nikander, T. Persson, K. Reinikainen, O. Selroos, et al. 1991. Comparison of a beta 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma. N. Engl. J. Med. 325:388-392.
30. 30. Dewar, J. C., J. Wilkinson, A. Wheatley, N. S. Thomas, I. Doull, N. Morton, P. Lio, J. F. Harvey, S. B. Liggett, S. T. Holgate, and I. P. Hall. 1997. The glutamine 27 beta 2-adrenoreceptor polymorphism is associated with elevated IgE levels in asthmatic families. J. Allergy Clin. Immunol. 100:261-265.
31. 31. McGraw, D. W., S. L. Forbes, L. A. Kramer, and S. B. Liggett. 1998. Polymorphisms of the 5′ leader cistron of the human beta 2-adrenergic receptor regulate receptor expression. J. Clin. Invest. 102:1927-1932.